News from cardium therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 16, 2011, 04:15 ET Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones

Cardium Therapeutics (NYSE Amex: CXM) today presented its financial results for the first quarter ended March 31, 2011. (Photo:...


Mar 31, 2011, 04:30 ET Cardium Presents Fourth Quarter and Year-End 2010 Financial Results and Recent Developments

Cardium Therapeutics (NYSE AMEX: CXM) today presented highlights of financial results for its fourth quarter and fiscal year ended December 31, 2010, ...


Mar 08, 2011, 09:00 ET Positive Findings From Excellagen Matrix Clinical Study Published in Peer-Reviewed Journal Wound Repair and Regeneration

Cardium Therapeutics (NYSE Amex: CXM) today announced the publication of positive findings from the Company's Matrix Phase 2b clinical study. The...


Jan 24, 2011, 09:00 ET Cardium's Exchange Listing Compliance Plan Accepted by NYSE Amex

Cardium Therapeutics (NYSE Amex: CXM) reported that its exchange listing compliance plan submitted on December 2, 2010 has been accepted by the NYSE...


Jan 18, 2011, 09:00 ET Cardium Announces Plans to Introduce Cerex™ to Support Cognitive Performance Expanding the MedPodium™ Modern Lifestyle Product Line

Cardium Therapeutics (NYSE Amex: CXM) today announced plans to introduce non-prescription Cerex™ (Panax quinquefolius) easy use 200 mg capsules, a...


Jan 06, 2011, 09:00 ET Cardium to Present at OneMedForum San Francisco 2011 Conference

Cardium Therapeutics (NYSE Amex: CXM) today announced today that it is scheduled to present at the OneMedForum Finance Conference for Emerging...


Dec 28, 2010, 09:00 ET Cardium Reports Excellagen Matrix Clinical Study Results Accepted for Publication by Peer-Reviewed Journal, and Updates Product Plans

Cardium Therapeutics (NYSE Amex: CXM) today reported that data from the Company's Matrix Phase 2b clinical study has been accepted for publication in ...


Dec 02, 2010, 09:00 ET Cardium Reports on Exchange Listing Deficiency and Compliance Plan

Cardium Therapeutics (NYSE Amex: CXM) reported on a communication from the staff of the company's current listing exchange indicating that it...


Nov 18, 2010, 09:00 ET Cardium Announces Co-Development and Strategic Licensing Agreement with BioZone Laboratories for Expansion of MedPodium Portfolio

Cardium Therapeutics (NYSE Amex: CXM) today announced a co-development and strategic licensing agreement with BioZone Laboratories, Inc. ("BioZone")...


Nov 15, 2010, 09:00 ET Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development

Cardium Therapeutics (NYSE Amex: CXM) reported on the presentation of results from the Company's sponsored preclinical research at the American Heart ...


Nov 09, 2010, 09:00 ET Cardium Reports on Third Quarter 2010 Financial Results and Recent Developments

Cardium Therapeutics (NYSE Amex: CXM) today reported highlights and financial results for its third quarter ended September 30, 2010. Highlights of...


Nov 08, 2010, 09:00 ET Cardium to Present at the LifeTech Capital Miami Medical Investors Conference

Cardium Therapeutics (NYSE Amex: CXM) announced today that Christopher J. Reinhard, Cardium's Chairman and Chief Executive Officer will present at...


Nov 03, 2010, 09:00 ET Cardium Awarded Grant Under Qualifying Therapeutic Discovery Project Program

Cardium Therapeutics (NYSE AMEX: CXM) today announced that it was awarded a cash grant of approximately $245,000 under the U.S. Government's...


Oct 13, 2010, 09:00 ET Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process

Cardium Therapeutics (NYSE Amex: CXM) today reported on new preclinical research findings that Excellagen, a topically applied formulated collagen...


Sep 29, 2010, 09:00 ET Cardium Gains Exclusive Access to Novel Polymer-Based Nitric Oxide Technology for Expansion of Wound Healing Product Portfolio

Cardium Therapeutics (NYSE Amex: CXM) announced that it has gained exclusive access to commercial development rights for certain novel...


Sep 20, 2010, 09:00 ET Cardium to Present at 10th Annual Biotech in Europe Investor Forum

Cardium Therapeutics (NYSE Amex: CXM) announced today that Christopher J. Reinhard, Cardium's Chairman and Chief Executive Officer will present at...


Sep 09, 2010, 09:25 ET Cardium Announces Appexium™, a New Weight Loss Management Dietary Supplement to Expand MedPodium's Healthy Lifestyle Product Initiative

Cardium Therapeutics (NYSE Amex: CXM) today announced the addition of a new weight management product, Appexium™, to Cardium's MedPodium™ product...


Sep 09, 2010, 09:15 ET Cardium to Present at the Rodman & Renshaw 12th Annual Healthcare Investment Conference

Cardium Therapeutics (NYSE Amex: CXM) announced today that Christopher J. Reinhard, Cardium's Chairman and Chief Executive Officer will present at...


Jul 07, 2010, 09:00 ET Cardium Regains Listing Compliance With NYSE Amex

Cardium Therapeutics (NYSE Amex: CXM) today reported that the Company has received a letter from the NYSE Amex LLC informing Cardium that it has now...


Jun 23, 2010, 09:00 ET Cardium Reports on Compliance of NYSE Amex Exchange Listing Guidelines

Cardium Therapeutics (NYSE Amex: CXM) today reported on its exchange listing compliance with NYSE Amex LLC (formerly the American Stock Exchange)....


Jun 14, 2010, 09:00 ET Cardium Announces Dominique Dawes, Olympic Champion, as Web-Based Spokesperson for New MedPodium Podiatry-Focused Advanced Skin Care Product Line

Cardium Therapeutics (NYSE Amex: CXM) today announced Dominique Dawes, an Olympic champion, as the official web-based spokesperson for the Company's...


Jun 10, 2010, 09:00 ET Cardium Announces Master Services Agreement With bioRASI for Planned Late-Stage Clinical Study and Commercialization Activities for Generx Product Candidate in International Markets

Cardium Therapeutics (NYSE Amex: CXM) today announced that it has entered into a Master Services Agreement with bioRASI, an international contract...


Jun 08, 2010, 09:00 ET Cardium Announces Collagen Supply Agreement with Devro Medical for Planned Market Launch of Excellagen Product Candidate and Reports on Further Positive Healing Effects

Cardium Therapeutics (NYSE Amex: CXM) today announced that its wholly-owned subsidiary, Tissue Repair Company, has entered into a multi-year supply...


May 10, 2010, 04:15 ET Cardium Reports on First Quarter 2010 Financial Results and Recent Developments

Cardium Therapeutics (NYSE Amex: CXM) today reported highlights and financial results for its first quarter ended March 31, 2010. Highlights of the...


May 07, 2010, 09:00 ET Cardium to Present at MDB Capital Group's 2010 Bright Lights Conference

Cardium Therapeutics (NYSE Amex: CXM) has been invited to present at the 2010 MDB Capital Group's Bright Lights Conference. The conference will be...